fashion -WSS

fashion

author：Wikipedia 2025-09-28 12:32:10 - browse：157

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： New Ultima Genomics DNA sequencer can read genome for $100

WSS

Readout Newsletter: Bluebird, CVS, Contineum

Juul spent big to court Black leaders to promote its e

Readout Newsletter: Bluebird, CVS, Contineum

What we need to know about Arena Bioworks

Cognito secures funding to test medical device for Alzheimer's

App could help diagnose ear infections more accurately — and at home

leisure time

fashion

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Stop the failed accountable care organization experiment

How to save PrEP access — and even expand it

Congressmen charge Covid hearing ‘could have been an email’

Jerome Adams on the need for new antivirals for Covid

New Ultima Genomics DNA sequencer can read genome for $100

Guidelines to prevent youth baseball injuries need more muscle

Cognito secures funding to test medical device for Alzheimer's

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Leading voice in opioid treatment defends methadone clinic system

focus

Cognito secures funding to test medical device for Alzheimer's

SAMSHA loosens regulations on methadone treatment centers

Do digital therapeutics have a future in medicine?

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Quicker fix for pulse oximeters urged during FDA public meeting

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

focus

entertainment

knowledge

hotspot